CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-14 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −156 | $76.37 | $12K | 36,270 |
| 2023-09-14 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units | −314 | 314 | ||
| 2023-08-24 | BRYANT DOUGLAS C President & CEO | Grant or award | +1,461 | 536,295 | ||
| 2023-08-24 | BRYANT DOUGLAS C President & CEO | Shares withheld for taxes | −725 | $78.33 | $57K | 535,570 |
| 2023-08-24 | BRYANT DOUGLAS C President & CEO | Exercise or conversion · Restricted Stock Units | −1,461 | 0 | ||
| 2023-07-28 | Kroll Werner SVP, Research & Development | Grant or award | +1,170 | 30,188 | ||
| 2023-07-28 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −549 | $87.12 | $48K | 29,639 |
| 2023-07-28 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −1,170 | 1,170 | ||
| 2023-07-01 | Kroll Werner SVP, Research & Development | Grant or award | +981 | 29,236 | ||
| 2023-07-01 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −436 | $82.86 | $36K | 28,800 |
| 2023-07-01 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −981 | 0 | ||
| 2023-06-06 | Wilkins Joseph D Jr. Director | Grant or award | +2,248 | 4,161 | ||
| 2023-06-06 | Wilkins Joseph D Jr. Director | Exercise or conversion · Restricted Stock Units (Equity Grant) | −2,248 | 0 | ||
| 2023-06-06 | WIDDER KENNETH J Director | Grant or award | +2,248 | 22,297 | ||
| 2023-06-06 | WIDDER KENNETH J Director | Exercise or conversion · Restricted Stock Units (Equity Grant) | −2,248 | 0 | ||
| 2023-06-06 | Strobeck Matthew Director | Grant or award | +2,248 | 10,430 | ||
| 2023-06-06 | Strobeck Matthew Director | Exercise or conversion · Restricted Stock Units (Equity Grant) | −2,248 | 0 | ||
| 2023-06-06 | Smith Christopher M Director | Grant or award | +2,248 | 2,249 | ||
| 2023-06-06 | Smith Christopher M Director | Exercise or conversion · Restricted Stock Units (Equity Grant) | −2,248 | 0 | ||
| 2023-01-30 | Busky Joseph M Chief Financial Officer | Grant or award · Non-Qualified Stock Option | +21,012 | 21,012 |
Page 32 of 33 · 642 trades